Today: 28 May 2026
Snowflake Soars 33% After $6B AWS Agreement; Wall Street Turns Bullish
28 May 2026
2 mins read

Snowflake Soars 33% After $6B AWS Agreement; Wall Street Turns Bullish

New York, May 28, 2026, 11:03 EDT

  • Snowflake shares jumped after the company lifted its product revenue outlook for fiscal 2027.
  • Investors got a clearer AI-infrastructure story after a five-year, $6 billion AWS agreement.
  • Analysts raised their price targets. Valuation and usage-based sales are still key swings.

Snowflake Inc. shares rocketed over 33% late Thursday morning after the company reported a strong outlook and signed a $6 billion deal with Amazon Web Services, which is shifting the stock into the AI infrastructure spotlight. Shares last traded at $233.38, up $58.12. The stock touched $243.99 earlier in the session.

Investors have been debating if AI spending helps or hurts software companies. Snowflake cleared that up, saying more customers are turning to its platform to handle data for AI projects. The company also raised its full-year product revenue outlook.

Snowflake’s first-quarter revenue rose 33% to $1.39 billion. Product revenue, which comes from customers’ use of compute, storage, and data-transfer on the platform, was up 34% to $1.33 billion. The company raised its fiscal 2027 product revenue outlook to $5.84 billion, up from $5.66 billion. Remaining performance obligations increased 38% to $9.21 billion, Snowflake said.

Snowflake CEO Sridhar Ramaswamy called AI a “powerful tailwind” in the company’s latest release. CFO Brian Robins said Snowflake had 779 customers who spent over $1 million in the past year. Of those, 46 joined the $1 million-plus group during the quarter. Snowflake Investors

The AWS deal is also helping the rally. Reuters said Snowflake is getting five years of access to AWS Graviton processors and AI infrastructure, plus more product integration and joint sales through AWS Marketplace. Gil Luria at D.A. Davidson said the agreement “adds another element” to Snowflake’s growth path. Reuters

That flipped sentiment on the stock quickly. Reuters said at least 30 analysts boosted their price targets after the news, pushing the median target up to $280 from $230. Matt Britzman at Hargreaves Lansdown said the move showed how fast the mood can shift when a company proves AI is lifting real revenue instead of just turning up in slide decks.

William Blair analysts said the results showed a “clear inflection for AI adoption” among Snowflake clients, according to Investopedia. Wedbush bumped its target to $280 from $270, saying Snowflake’s infrastructure might be a moat. Shares had been down about 20% for the year going into Thursday, but the rally brought them back into the green for 2026. Investopedia

Snowflake isn’t the only focus in software right now. Investors are separating software names into two groups: those that could get squeezed by AI agents, and those that might supply the data backbone for those same tools. With Snowflake’s stronger outlook, deeper AWS partnership, and growth in AI tool use, buyers had enough to put it in the latter camp.

Other stocks in the space are getting attention too. Datadog is valued at about $82.6 billion, a little higher than Snowflake, which has a $79.4 billion market value. MongoDB trades close to $26.3 billion. All three are high-growth software names tied to the debate over AI spending.

Snowflake shares are still expensive. Reuters said the company trades at about 85 times estimated earnings, similar to Datadog but much higher than MongoDB. That multiple shows investors are paying up for forecasted profit growth. If AI initiatives in the enterprise stay in testing or if this quarter’s pickup fades, Snowflake’s usage-based setup could put its new outlook at risk.

Snowflake is getting buyers on the turn for now. The company beat the numbers. Wall Street also has a partnership story, a capacity angle and fresh evidence that AI demand is already filling the income statement.

Stock Market Today

  • Why Zillow (Z) Stands Out as a Strong Growth Stock
    May 28, 2026, 11:23 AM EDT. Zillow (Z) emerges as a strong growth stock supported by Zacks Premium research tools that provide daily updates on stock rankings, including the Zacks Rank and Style Scores. These scores assess stocks based on value, growth, and momentum factors, helping investors identify potential market outperformers. Zillow benefits from the Zacks proprietary model that uses earnings estimate revisions to predict performance, with Strong Buy stocks historically delivering an average annual return of +23.7%, significantly beating the S&P 500. The comprehensive evaluation combining value, growth, and momentum metrics underscores Zillow's potential for sustained growth and favorable market trends.

Latest articles

Snowflake Soars 33% After $6B AWS Agreement; Wall Street Turns Bullish

Snowflake Soars 33% After $6B AWS Agreement; Wall Street Turns Bullish

28 May 2026
New York, May 28, 2026, 11:03 EDT Snowflake Inc. shares rocketed over 33% late Thursday morning after the company reported a strong outlook and signed a $6 billion deal with Amazon Web Services, which is shifting the stock into the AI infrastructure spotlight. Shares last traded at $233.38, up $58.12. The stock touched $243.99 earlier in the session. Investors have been debating if AI spending helps or hurts software companies. Snowflake cleared that up, saying more customers are turning to its platform to handle data for AI projects. The company also raised its full-year product revenue outlook. Snowflake’s first-quarter revenue
Super Micro Shares Move on Taiwan Server Seizure, AI Cloud Agreement

Super Micro Shares Move on Taiwan Server Seizure, AI Cloud Agreement

28 May 2026
Super Micro shares rose 6.2% to $40.57 Thursday after the company reported Taiwanese officials arrested three suspects and seized 50 servers linked to illegal exports to China. The company also announced a major AI-cloud deployment in Europe with Verda. Trading volume exceeded 18 million shares. Super Micro forecast quarterly revenue of $11 billion to $12.5 billion.
Eli Lilly’s $20 Billion M&A Push Moves Into Vaccines

Eli Lilly’s $20 Billion M&A Push Moves Into Vaccines

28 May 2026
Eli Lilly will acquire Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. for up to $3.83 billion in cash, gaining vaccine programs for shingles, staph infections, and Epstein-Barr virus. Shares rose about 5% after news of the deals and broader coverage for Zepbound and Foundayo. Curevo shareholders may receive up to $1.5 billion, LimmaTech $780 million, and Vaccine Company $1.55 billion.
Super Micro Shares Move on Taiwan Server Seizure, AI Cloud Agreement
Previous Story

Super Micro Shares Move on Taiwan Server Seizure, AI Cloud Agreement

Go toTop